Gentian Diagnostics ASA Navne-Aksjer NK -,01
- BID
3.39
- ASK
3.5
- 1,190 Units1,171 Units
- 07/23, 13:03:40 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
27.19%
Market Cap
-
P/E Ratio
65.62
Dividend Yield
1.06 %
Earnings per Share
0.07 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.39 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 01:03:40 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 3.49 | 3.36 |
| PREV. DAY'S PRICE | 3.38 | (07/22) |
| CHANGE DAY BEFORE | +0.01 | 0.30 % |
| 52 WEEK HIGH / LOW | 5.04 (01/29) | 3.06 (06/23) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.06 | 0.25 | 0.07 | 0.13 | 0.23 |
DIVIDENDS PER SHARE | 0.00 | 0.03 | 0.05 | 0.07 | 0.09 |
DIVIDEND YIELD IN % | 0.00 % | 1.02 % | 1.06 % | - | - |
DIVIDEND GROWTH IN % | - | - | 49.02 % | - | - |
PRICE - EARNINGS RATIO | - | 13.35 | 65.62 | 25.41 | 14.38 |
PRICE - BOOK RATIO | 4.36 | 3.12 | 4.24 | - | - |
PRICE - SALES RATIO | 4.74 | 4.06 | 4.95 | - | - |
PRICE - CASH FLOW RATIO | 41.41 | 45.91 | 20.51 | - | - |
Master Data
| WKN | A2DLP7 |
| ISIN | NO0010748866 |
| SYMBOL | 6FK |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | GENTIAN DIAGNOST. NO -,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -1.78 % | 5.40 % | -17.41 % | -32.93 % | -27.19 % | -11.94 % | -40.71 % | -27.35 % |
| HIGH | 3.61 | 3.61 | 4.21 | 5.04 | 5.04 | 5.30 | 8.68 | 5.04 |
| LOW | 3.24 | 3.06 | 3.06 | 3.06 | 3.06 | 2.57 | 2.57 | 3.06 |
Dividende
pro Aktie
Company profile
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. Its products include GCAL Calprotrectin, Crystatin C, Retinol-Binding Protein, Canine CRP, SARS-CoV-2 Total Ab, NT-proBNP Pre-Launch, BÜHLMANN products, IFU documents, and safety data sheets. The company was founded by Erling M. H. Sundrehagen and Bård Sundrehagen in 2001 and is headquartered in Moss, Norway.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.